Cargando…

A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M

BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zai, Xiaodong, Yang, Qiaoling, Liu, Kun, Li, Ruihua, Qian, Mengying, Zhao, Taoran, Li, Yaohui, Yin, Ying, Dong, Dayong, Fu, Ling, Li, Shanhu, Xu, Junjie, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442703/
https://www.ncbi.nlm.nih.gov/pubmed/28535754
http://dx.doi.org/10.1186/s12864-017-3800-9
_version_ 1783238448556015616
author Zai, Xiaodong
Yang, Qiaoling
Liu, Kun
Li, Ruihua
Qian, Mengying
Zhao, Taoran
Li, Yaohui
Yin, Ying
Dong, Dayong
Fu, Ling
Li, Shanhu
Xu, Junjie
Chen, Wei
author_facet Zai, Xiaodong
Yang, Qiaoling
Liu, Kun
Li, Ruihua
Qian, Mengying
Zhao, Taoran
Li, Yaohui
Yin, Ying
Dong, Dayong
Fu, Ling
Li, Shanhu
Xu, Junjie
Chen, Wei
author_sort Zai, Xiaodong
collection PubMed
description BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3800-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5442703
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54427032017-05-25 A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M Zai, Xiaodong Yang, Qiaoling Liu, Kun Li, Ruihua Qian, Mengying Zhao, Taoran Li, Yaohui Yin, Ying Dong, Dayong Fu, Ling Li, Shanhu Xu, Junjie Chen, Wei BMC Genomics Research Article BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3800-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-23 /pmc/articles/PMC5442703/ /pubmed/28535754 http://dx.doi.org/10.1186/s12864-017-3800-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zai, Xiaodong
Yang, Qiaoling
Liu, Kun
Li, Ruihua
Qian, Mengying
Zhao, Taoran
Li, Yaohui
Yin, Ying
Dong, Dayong
Fu, Ling
Li, Shanhu
Xu, Junjie
Chen, Wei
A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title_full A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title_fullStr A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title_full_unstemmed A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title_short A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
title_sort comprehensive proteogenomic study of the human brucella vaccine strain 104 m
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442703/
https://www.ncbi.nlm.nih.gov/pubmed/28535754
http://dx.doi.org/10.1186/s12864-017-3800-9
work_keys_str_mv AT zaixiaodong acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT yangqiaoling acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liukun acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liruihua acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT qianmengying acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT zhaotaoran acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liyaohui acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT yinying acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT dongdayong acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT fuling acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT lishanhu acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT xujunjie acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT chenwei acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT zaixiaodong comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT yangqiaoling comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liukun comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liruihua comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT qianmengying comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT zhaotaoran comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT liyaohui comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT yinying comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT dongdayong comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT fuling comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT lishanhu comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT xujunjie comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m
AT chenwei comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m